The DOI matches its Crossref record; 73 of the 75 references it cites were found in a registry or an index.
Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review
Open accessAbstract
The increasing legal availability of cannabis has important implications for road safety. This systematic review characterised the acute effects of Δ9-THC on driving performance and driving-related cognitive skills, with a particular focus on the duration of Δ9-THC-induced impairment. Eighty publications and 1534 outcomes were reviewed. Several measures of driving performance and driving-related cognitive skills (e.g. lateral control, tracking, divided attention) demonstrated impairment in meta-analyses of “peak” Δ9-THC effects (p’s<0.05). Multiple meta-regression analyses further found that regular cannabis users experianced less impairment than ‘other’ (mostly occasional) cannabis users (p = 0.003) and that the magnitude of oral (n = 243 effect estimates [EE]) and inhaled (n = 481 EEs) Δ9-THC-induced impairment depended on various factors (dose, post-treatment time interval, the performance domain (skill) assessed) in other cannabis users (p’s<0.05). The latter model predicted that most driving-related cognitive skills would ‘recover’ (Hedges’ g=–0.25) within ∼5-hs (and almost all within ∼7-hs) of inhaling 20 mg of Δ9-THC; oral Δ9-THC-induced impairment may take longer to subside. These results suggest individuals should wait at least 5 -hs following inhaled cannabis use before performing safety-sensitive tasks.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The concurrent use of cannabis and alcohol produces greater driving impairment than cannabis alone [25].”
From Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits (2025) · cites this paper as [25]
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,603
Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,417
PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
A general and simple method for obtaining R 2 from generalized linear mixed‐effects models
Nakagawa, S., & Schielzeth, H. (2013) · Methods in Ecology and Evolution · doi:10.1111/j.2041-210x.2012.00261.x · Cited by 10,356
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2021) · doi:10.1002/9781119558378 · Cited by 9,799
Cochrane Handbook for Systematic Reviews of Interventions
Higgins, J. P. T., Green, S., & Ben Van Den, A. (2020) · International Coaching Psychology Review · doi:10.53841/bpsicpr.2020.15.2.123 · Cited by 5,670
Verhagen, A. P., de Vet, H. C. W., de Bie, R. A., Kessels, A. G. H., Boers, M., Bouter, L. M., & Knipschild, P. G. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00131-0 · Cited by 2,470
Jones, H. E. (2010) · Paediatric and Perinatal Epidemiology · doi:10.1111/j.1365-3016.2010.01108.x · Cited by 1,447
Research works printed but not linked: 1
- Arkell, 2020, Using per se limits to define cannabis-induced driving impairment: problems, pitfalls and possible solutions, Traffic Inj. Prev.
Cited by
Sorted by citations
Solmi, M., Toffol, M. D., Kim, J. Y., Choi, M., Stubbs, B., Thompson, T., Firth, J., Miola, A., Croatto, G., Baggio, F., et al. (2023) · BMJ · doi:10.1136/bmj-2022-072348 · Cited by 322
Fischer, B., Robinson, T., Bullen, C., Curran, V., Jutras-Aswad, D., Medina-Mora, M. E., Pacula, R. L., Rehm, J., Room, R., Brink, W. V. D., et al. (2022) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103381 · Cited by 236
Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits
Hoch, E., Volkow, N. D., Friemel, C. M., Lorenzetti, V., Freeman, T. P., & Hall, W. (2025) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01880-2 · Cited by 139
“The concurrent use of cannabis and alcohol produces greater driving impairment than cannabis alone [25].”
Dellazizzo, L., Potvin, S., Giguère, S., & Dumais, A. (2022) · Addiction · doi:10.1111/add.15764 · Cited by 120
Shah, S., Schwenk, E. S., Sondekoppam, R. V., Clarke, H. A., Zakowski, M. I., Lynn, R. R., Yeung, B., Nicholson, K., Schwartz, G. S., Hooten, W. M., et al. (2023) · Regional Anesthesia & Pain Medicine · doi:10.1136/rapm-2022-104013 · Cited by 113
Driving Performance and Cannabis Users’ Perception of Safety
Marcotte, T. D., Umlauf, A., Grelotti, D. J., Sones, E. G., Sobolesky, P. M., Smith, B. E., Hoffman, M. A., Hubbard, J. A., Severson, J., Huestis, M. A., et al. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.4037 · Cited by 100
The why behind the high: determinants of neurocognition during acute cannabis exposure
Ramaekers, J. G., Mason, N. L., Kloft, L., & Theunissen, E. L. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-021-00466-4 · Cited by 76
Pearlson, G. D., Stevens, M. C., & D'Souza, D. C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.689444 · Cited by 72
“Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations
MacCallum, C. A., Lo, L. A., & Boivin, M. (2021) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2021.05.002 · Cited by 71
McCartney, D., Arkell, T. R., Irwin, C. G., Kevin, R. C., & McGregor, I. S. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.11.004 · Cited by 56
Self-citationCannabinoids, Insomnia, and Other Sleep Disorders
Lavender, I., McGregor, I. S., Suraev, A. S., Grunstein, R. R., & Hoyos, C. M. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.04.151 · Cited by 52
Self-citationAn overview on synthetic and biological activities of cannabidiol (CBD) and its derivatives
Wang, X., Zhang, H., Liu, Y., Yang, X., Yang, B., Li, H., & Chen, L. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106810 · Cited by 57
MacCallum, C. A., Eadie, L., Barr, A. M., Boivin, M. R., & Lu, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.633168 · Cited by 72
Arkell, T., McCartney, D., & McGregor, I. (2021) · Australian Journal of General Practice · doi:10.31128/ajgp-02-21-5840 · Cited by 30
Self-citationSimulated driving performance among daily and occasional cannabis users
Brooks‐Russell, A., Brown, T. L., Friedman, K., Wrobel, J., Schwarz, J., Dooley, G., Ryall, K. A., Steinhart, B., Amioka, E., Milavetz, G., et al. (2021) · Accident Analysis & Prevention · doi:10.1016/j.aap.2021.106326 · Cited by 46
Han, B. H., Brennan, J. J., Orozco, M. A., Moore, A. A., & Castillo, E. M. (2023) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18180 · Cited by 44
Sevigny, E. L. (2021) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2021.03.003 · Cited by 42
Medicinal cannabis and driving: the intersection of health and road safety policy
Perkins, D., Brophy, H., McGregor, I. S., O’Brien, P., Quilter, J., McNamara, L., Sarris, J. J., Stevenson, M., Gleeson, P., Sinclair, J., et al. (2021) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103307 · Cited by 37
Self-citationGrimison, P., Mersiades, A. J., Kirby, A. C., Tognela, A., Olver, I., Morton, R. L., Haber, P., Walsh, A., Lee, Y., Abdi, E. A., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.23.01836 · Cited by 40
Can cannabis kill? Characteristics of deaths following cannabis use in England (1998–2020)
Rock, K. L., Englund, A., Morley, S., Rice, K., & Copeland, C. S. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221115760 · Cited by 32
Tetrahydrocannabinol and Cannabidiol in Tourette Syndrome
Mosley, P. E., Webb, L., Suraev, A. S., Hingston, L., Turnbull, T. A., Foster, K. A., Ballard, E. L., Gomes, L., Mohan, A., Sachdev, P. S., et al. (2023) · NEJM Evidence · doi:10.1056/evidoa2300012 · Cited by 32
Self-citationThe Place of Cannabinoids in the Treatment of Gynecological Pain
Sinclair, J., Abbott, J. A., Proudfoot, A., & Armour, M. (2023) · Drugs · doi:10.1007/s40265-023-01951-z · Cited by 31
Psychotropic drug abuse in pregnancy and its impact on child neurodevelopment: A review
Etemadi-Aleagha, A., & Akhgari, M. (2022) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v11.i1.1 · Cited by 30
Wickens, C. M., Wright, M., Mann, R. E., Brands, B., Ciano, P. D., Stoduto, G., Fares, A., Matheson, J., George, T. P., Rehm, J. T., et al. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110570 · Cited by 27
Fitzgerald, R. L., Umlauf, A., Hubbard, J. A., Hoffman, M. A., Sobolesky, P. M., Ellis, S., Grelotti, D. J., Suhandynata, R. T., Huestis, M. A., Grant, I., et al. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad054 · Cited by 27
Does the “Entourage Effect” in Cannabinoids Exist? A Narrative Scoping Review
Simei, J. L. Q., Souza, J. D. R., Lisboa, J. R., Campos, A. C., Guimarães, F. S., Zuardi, A. W., & Crippa, J. A. S. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0052 · Cited by 26
Lavender, I., McCartney, D., Marshall, N. S., Suraev, A. S., Irwin, C. G., D'Rozario, A. L., Gordon, C. J., Saini, B., Grunstein, R. R., Yee, B. J., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-071148 · Cited by 22
Self-citationSimei, J. L. Q., Souza, J. D. R., Pedrazzi, J. F. C., Guimarães, F. S., Campos, A. C., Zuardi, A. W., Hallak, J. E. C., & Crippa, J. A. S. (2024) · Pharmaceuticals · doi:10.3390/ph17121644 · Cited by 27
Brooks‐Russell, A., Wrobel, J., Brown, T. L., Bidwell, L. C., Wang, G. S., Steinhart, B., Dooley, G., & Kosnett, M. J. (2024) · Journal of Cannabis Research · doi:10.1186/s42238-024-00215-1 · Cited by 19
Considerations for Cannabinoids in Perioperative Care by Anesthesiologists
Laudański, K., & Wain, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030558 · Cited by 22
Lo, L. A., Christiansen, A. L., Strickland, J. C., Pistawka, C. A., Eadie, L., Vandrey, R. G., & MacCallum, C. A. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01847-w · Cited by 22
Cannabis Use and Cognitive Functioning Across the Lifespan
Meier, M. H., Olive, M. F., Jenks, O. A., & Wernik, S. R. (2024) · Current Addiction Reports · doi:10.1007/s40429-024-00571-1 · Cited by 20
Plumb, J., Demirel, S., Sackett, J., Russo, E. B., & Wilson-Poe, A. R. (2022) · Psychoactives · doi:10.3390/psychoactives1020008 · Cited by 14
Crash-involved THC-positive drivers in Norway have a high frequency of polysubstance use
Gjerde, H., Bogstrand, S. T., Jamt, R. E. G., & Vindenes, V. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.109800 · Cited by 16
Arkell, T. R., Manning, B., Downey, L. A., & Hayley, A. C. (2023) · CNS Drugs · doi:10.1007/s40263-023-01046-z · Cited by 15
Self-citationChoo, E. K., Trent, S. A., Nishijima, D. K., Eichelberger, A. H., Kazmierczak, S., Ye, Y., Brasel, K. J., Audett, A., & CHERPITEL, C. J. S. (2024) · Accident Analysis & Prevention · doi:10.1016/j.aap.2024.107459 · Cited by 15
Surgery-Related Considerations in Treating People Who Use Cannabis
Mims, M. M., Parikh, A. C., Sandhu, Z., DeMoss, N., Mhawej, R. I., & Queimado, L. (2024) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2024.2545 · Cited by 14
The “Next Day” Effects of Cannabis Use: A Systematic Review
McCartney, D., Suraev, A. S., & McGregor, I. S. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0185 · Cited by 14
Self-citationMartin, A. M. S., Flynn, L. T., Sefik, E., Luddy, C., Cortes-Briones, J., Skosnik, P. D., Pittman, B. P., Ranganathan, M., & D’Souza, D. C. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06356-0 · Cited by 14
Manning, B., Arkell, T. R., Hayley, A. C., & Downey, L. A. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241229524 · Cited by 14
Self-citationUsing Cannabis and CBD to Sleep: An Updated Review
Lavender, I., Garden, G., Grunstein, R. R., Yee, B. J., & Hoyos, C. M. (2024) · Current Psychiatry Reports · doi:10.1007/s11920-024-01564-7 · Cited by 16
A Clinical Framework for Assessing Cannabis-Related Impairment Risk
MacCallum, C. A., Lo, L. A., Pistawka, C. A., Christiansen, A. L., Boivin, M. R., & Snider-Adler, M. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.883517 · Cited by 13
Litvinova, O., Baral, B., Wochele‐Thoma, T., Matin, M., Tzvetkov, N. T., Adamska, O., Kamińska, A., Łapiński, M., Stolarczyk, A., & Atanasov, A. G. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1494018 · Cited by 13
Manning, B., Hayley, A. C., Catchlove, S. J., Shiferaw, B. A., Stough, C. K. K., & Downey, L. A. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231170360 · Cited by 13
Arkell, T. R., Abelev, S. V., Mills, L., Suraev, A. S., Arnold, J. C., Lintzeris, N., & McGregor, I. S. (2023) · Journal of Cannabis Research · doi:10.1186/s42238-023-00202-y · Cited by 11
Self-citationMiller, R. E., Brown, T. L., Wrobel, J., Kosnett, M. J., & Brooks‐Russell, A. (2022) · Traffic Injury Prevention · doi:10.1080/15389588.2022.2072492 · Cited by 11
Wickens, C. M., Stoduto, G., Ilie, G., Ciano, P. D., McDonald, A. J., Mistry, A., Alawi, A., Sharma, S., Hamilton, H. A., Nigatu, Y. T., et al. (2022) · Journal of Transport & Health · doi:10.1016/j.jth.2022.101402 · Cited by 11
Johnstad, P. G. (2022) · Drug Science Policy and Law · doi:10.1177/20503245221095228 · Cited by 12
Kosnett, M. J., Ma, M., Dooley, G., Wang, G. S., Friedman, K., Brown, T. L., Henthorn, T. K., & Brooks‐Russell, A. (2023) · Clinical Toxicology · doi:10.1080/15563650.2023.2214697 · Cited by 11
Mills, L., & Freeman, J. (2023) · Transportation Research Part F Traffic Psychology and Behaviour · doi:10.1016/j.trf.2023.06.015 · Cited by 10
Suraev, A. S., McCartney, D., Marshall, N. S., Irwin, C. G., Vandrey, R. G., Grunstein, R. R., D'Rozario, A. L., Gordon, C. J., Bartlett, D. J., Hoyos, C. M., et al. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06595-9 · Cited by 10
Self-citationZamarripa, C., Novak, M., Weerts, E., Vandrey, R., & Spindle, T. R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.964749 · Cited by 8
Attitudes toward driving after cannabis use: a systematic review
Boicu, B., Al-Hakim, D., Yuan, Y., & Brubacher, J. R. (2024) · Journal of Cannabis Research · doi:10.1186/s42238-024-00240-0 · Cited by 9
Rague, J. M., Ma, M., Dooley, G., Wang, G. S., Friedman, K., Henthorn, T. K., Brooks‐Russell, A., & Kosnett, M. J. (2023) · Clinical Toxicology · doi:10.1080/15563650.2023.2173076 · Cited by 9
Mills, L., Freeman, J., & Rowland, B. (2023) · Drug and Alcohol Review · doi:10.1111/dar.13705 · Cited by 9
Barkholtz, H. M., & Bates, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-36770-5 · Cited by 9
Ney, L. J., Akóṣílè, W., Davey, C. G., Pitcher, L., Felmingham, K. L., Mayo, L. M., Hill, M. N., & Strodl, E. S. (2023) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2276309 · Cited by 9
Manning, B., Hayley, A. C., Catchlove, S. J., Stough, C. K. K., & Downey, L. A. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.02.002 · Cited by 9
Intoxication due to Δ9-tetrahydrocannabinol is characterized by disrupted prefrontal cortex activity
Karunakaran, K. D., Pascale, M. P., Ozana, N. N., Potter, K. W., Pachas, G. N., Evins, A. E., & Gilman, J. M. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01876-5 · Cited by 9
The Development of Cannabinoids as Therapeutic Agents in the United States
Murray, C. H., Gannon, B. M., Winsauer, P. J., Cooper, Z. D., & Delatte, M. S. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001121 · Cited by 10
Testing for cannabis intoxication: Current issues and latest advancements
Johnson, O. E., Miskelly, G. M., & Rindelaub, J. D. (2021) · Wiley Interdisciplinary Reviews Forensic Science · doi:10.1002/wfs2.1450 · Cited by 9
Perceptions of the Risk and Social Acceptability of Driving Under the Influence of Cannabis
Pollard, M. A., Drakes, D. H., & Harris, N. (2022) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-022-00879-x · Cited by 9
High Traffic—The Quest for a Reliable Test of Cannabis Impairment
Ramaekers, J. G., Vinckenbosch, F. R. J., & Gilman, J. M. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.2309 · Cited by 9
Suraev, A. S., McCartney, D., Kevin, R. C., Gordon, R., Grunstein, R. R., Hoyos, C. M., & McGregor, I. S. (2024) · Drug Testing and Analysis · doi:10.1002/dta.3658 · Cited by 8
Self-citationCannabis use before safety-sensitive work: What delay is prudent?
Beckson, M., Hagtvedt, R., & Els, C. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.12.011 · Cited by 8
A systematic review of oculomotor deficits associated with acute and chronic cannabis use
Manning, B., Downey, L. A., Narayan, A. J., & Hayley, A. C. (2023) · Addiction Biology · doi:10.1111/adb.13359 · Cited by 7
Brown, T. L., Banz, B. C., Schmitt, R., Gaffney, G., Milavetz, G., Camenga, D. R., Li, K., Brooks‐Russell, A., & Vaca, F. E. (2022) · Traffic Injury Prevention · doi:10.1080/15389588.2022.2124803 · Cited by 7
The role of cannabinoid-mediated signaling pathways and mechanisms in brain disorders
Liu, S., & Ma, Z. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111653 · Cited by 7
“Wake-and-bake” cannabis use: Predictors and cannabis-related outcomes of use shortly after waking
Calhoun, B. H., Graupensperger, S. A., Fairlie, A. M., Walukevich‐Dienst, K., Patrick, M. E., & Lee, C. M. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.109937 · Cited by 7
Gorziza, R. P., Valdes, N. B., Tinoco, M., & Almirall, J. R. (2023) · Forensic Chemistry · doi:10.1016/j.forc.2023.100514 · Cited by 7
Effects of different methods of cannabis use on cognition and blood THC: A systematic review.
Behzad, D., Patel, S., Besa, R., Chan, A. W. H., Chen, S., Rueda, S., Ruocco, A. C., & Di Ciano, P. (2025) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111399 · Cited by 7
Cannabis Effects on Driving Performance: Clinical Considerations
Costales, B., Babalonis, S. L., Brown, J. D., & Goodin, A. J. (2023) · Medical Cannabis and Cannabinoids · doi:10.1159/000528714 · Cited by 6
Brunette, M. F., Roth, R. M., Trask, C. L., Khokhar, J. Y., Ford, J., Park, S. H., Hickey, S. M., Zeffiro, T. A., & Xie, H. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae097 · Cited by 6
Understanding the Role of Endocannabinoids in Posttraumatic Stress Disorder
Ney, L. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125527 · Cited by 6
Effects of psychotropic drugs on ocular parameters relevant to traffic safety: A systematic review
Arkell, T. R., Brooks‐Russell, A., Downey, L. A., Shiferaw, B. A., Brown, T. L., Sherrick, J., & Hayley, A. C. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104831 · Cited by 6
Self-citationDavis, S., Betz, M. E., Hill, L. L., Eby, D. W., Jones, V., Mielenz, T. J., Molnar, L. J., Strogatz, D. S., Clancy, K., Li, G., et al. (2023) · Traffic Injury Prevention · doi:10.1080/15389588.2023.2180736 · Cited by 6
Complexity of Translating Analytics to Recent Cannabis Use and Impairment
DeGregorio, M. W., Kao, C.-J., & Wurz, G. T. (2024) · Journal of AOAC International · doi:10.1093/jaoacint/qsae015 · Cited by 6
Levine, M. S., & LoVecchio, F. (2021) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2021.04.013 · Cited by 6
Managing the high: developing legislation and detection methods for cannabis impairment
Arkell, T. R., Hayley, A. C., & Downey, L. A. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-021-00500-5 · Cited by 6
Self-citationDivergence in cannabis and alcohol use disorder prevalence trends from 2002 to 2019
Acuff, S. F., & Strickland, J. C. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2024.112521 · Cited by 5
Schranz, A., Knoche, A., Rosenkranz, M., Verthein, U., & Manthey, J. (2026) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2026.101593 · Cited by 6
Drug‐impaired driving and traffic collisions: Study on a cross section of the Italian population
Odoardi, S., Biosa, G., Mestria, S., Valentini, V., Giovanni, N. D., Cittadini, F., & Rossi, S. S. (2022) · Drug Testing and Analysis · doi:10.1002/dta.3366 · Cited by 5
Cannabis use disorder contributes to cognitive dysfunction in Veterans with traumatic brain injury
Esmaeili, A., Dismuke‐Greer, C. E., Pogoda, T. K., Amuan, M. E., Garcia, C., Negro, A. D., Myers, M., Kennedy, E., Cifu, D. X., & Pugh, M. J. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1261249 · Cited by 5
Substance use and driver fatality in Norway: An expanded case-control study
Gjerde, H., Jamt, R. E. G., Stenehjem, J. S., & Bogstrand, S. T. (2024) · Traffic Injury Prevention · doi:10.1080/15389588.2024.2392274 · Cited by 5
Medicinal Cannabis and Consumer Vulnerability in Australia: A Nexus of Policy and Market Factors
Gething, K., Erku, D., & Scuffham, P. (2025) · Health Expectations · doi:10.1111/hex.70176 · Cited by 5
Sex differences in the acute effects of cannabis on human cognition: A systematic review
Matheson, J., Behzad, D., Zakala, C., Hawken, T., Brands, B., Foll, B. L., Wickens, C. M., Ruocco, A. C., Rodak, T., & Ciano, P. D. (2025) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2025.101215 · Cited by 5
Ho, S. W. C., Yuen Lung, W. O. N. G., & Chung, P. H. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.929016 · Cited by 5
Stefanidis, K. B., Schiemer, C., Mieran, T., & Summers, M. J. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.10.051 · Cited by 5
Macdonald, S., & Zhao, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39873 · Cited by 4
Schiemer, C., Horswill, M. S., Hill, A., Summers, M. J., & Stefanidis, K. B. (2024) · Journal of Safety Research · doi:10.1016/j.jsr.2024.12.004 · Cited by 4
Christen, S. E., Bekka, E., Schmid, Y., Benowitz, N. L., & Liakoni, E. (2025) · Swiss Medical Weekly · doi:10.57187/s.4346 · Cited by 4
Cannabis, cognitive impairment and car crash risk
Preuss, U. W., Hoch, E., & Wong, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89862-1.00027-1 · Cited by 4
Acute and chronic impact of cannabis on human cognition
Matheson, J., & Foll, B. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89862-1.00004-0 · Cited by 4
Aitken, B., Hayley, A. C., Ford, T. C., Geier, L., Shiferaw, B. A., & Downey, L. A. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231200878 · Cited by 4
White, M. A., & Burns, N. R. (2022) · Drug Science Policy and Law · doi:10.1177/20503245221119046 · Cited by 5
Identifying EEG markers related to acute cannabis consumption: A systematic review
Schiemer, C., Summers, M. J., & Stefanidis, K. B. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106092 · Cited by 3
Buckley, L., Mieran, T., & Armstrong, K. A. (2025) · Transport Reviews · doi:10.1080/01441647.2025.2561613 · Cited by 3
Ciano, P. D., Foll, B. L., Zhao, S., Byrne, P., Elzohairy, Y., Brubacher, J. R., McGrath, M. J., Brands, B., Chen, S., Wang, W., et al. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251370975 · Cited by 3
Schumacher, A., Crescenzo, L. A. D., Yellman, M. A., & Sauber‐Schatz, E. K. (2024) · Journal of Safety Research · doi:10.1016/j.jsr.2024.09.017 · Cited by 3
Corbett, M. R., Botch‐Jones, S., Winecker, R. E., & Yeatman, T. (2024) · Journal of Analytical Toxicology · doi:10.1093/jat/bkae089 · Cited by 3
Metadata
- Authors
- McCartney, D., Arkell, T. R., Irwin, C., & McGregor, I. S.
- Affiliations
- The University of Sydney (AU)
- Griffith University (AU)
- Corresponding author
- McCartney, Danielle
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 126
- Pages
- 175-193
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W3121363966
- Cited by
- 170
- References
- 75
- Citations by year
- 2026: 23 · 2025: 30 · 2024: 40 · 2023: 37 · 2022: 26 · 2021: 14
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Neuroscience & Biobehavioral Reviews (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Griffith Research Online (submittedVersion, cc-by-nc-nd)
- Funders
- University of Sydney
- Griffith University
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Physical Sciences › Engineering › Safety, Risk, Reliability and Quality › Traffic and Road Safety
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Keywords
- delta-9-tetrahydrocannabinol, cannabis, driving performance, cognitive impairment, road safety, inhaled cannabis, divided attention, lateral control, tracking, dosage effect
- MeSH terms
- Attention, Humans, Marijuana Smoking, Psychomotor Performance, Dronabinol, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review